These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31028165)

  • 41. Intra-individual comparison of
    Ferreira G; Iravani A; Hofman MS; Hicks RJ
    Cancer Imaging; 2019 May; 19(1):23. PubMed ID: 31092293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Semiquantitative Parameters in PSMA-Targeted PET Imaging with [
    Sahakyan K; Li X; Lodge MA; Werner RA; Bundschuh RA; Bundschuh L; Kulkarni HR; Schuchardt C; Baum RP; Pienta KJ; Pomper MG; Ross AE; Gorin MA; Rowe SP
    Mol Imaging Biol; 2020 Feb; 22(1):181-189. PubMed ID: 31115751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography.
    Li L; Wan L; Zhao H; Wang C; Wei W; Liu J
    Quant Imaging Med Surg; 2023 Aug; 13(8):5182-5194. PubMed ID: 37581077
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intraindividual Comparison of
    Dietlein F; Kobe C; Hohberg M; Zlatopolskiy BD; Krapf P; Endepols H; Täger P; Hammes J; Heidenreich A; Persigehl T; Neumaier B; Drzezga A; Dietlein M
    J Nucl Med; 2020 May; 61(5):729-734. PubMed ID: 31628219
    [No Abstract]   [Full Text] [Related]  

  • 46.
    Liu T; Liu C; Zhang Z; Zhang N; Guo X; Xia L; Jiang J; Xie Q; Yan K; Rowe SP; Zhu H; Yang Z
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4508-4516. PubMed ID: 34170361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biochemical Recurrence of Prostate Cancer: Initial Results with [
    Giesel FL; Will L; Kesch C; Freitag M; Kremer C; Merkle J; Neels OC; Cardinale J; Hadaschik B; Hohenfellner M; Kopka K; Haberkorn U; Kratochwil C
    J Nucl Med; 2018 Apr; 59(4):632-635. PubMed ID: 29419475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PET Using a GRPR Antagonist
    Zhang J; Niu G; Fan X; Lang L; Hou G; Chen L; Wu H; Zhu Z; Li F; Chen X
    J Nucl Med; 2018 Jun; 59(6):922-928. PubMed ID: 29123014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, preclinical evaluation, and first-in-human study of Al
    Wu Y; Zhang X; Zhou H; Xu B; Tian J; Sun S; Zhang J
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2774-2785. PubMed ID: 35396969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A PSMA Ligand Labeled with Cobalt-55 for PET Imaging of Prostate Cancer.
    Dam JH; Olsen BB; Baun C; Høilund-Carlsen PF; Thisgaard H
    Mol Imaging Biol; 2017 Dec; 19(6):915-922. PubMed ID: 28924629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer.
    Schottelius M; Wurzer A; Wissmiller K; Beck R; Koch M; Gorpas D; Notni J; Buckle T; van Oosterom MN; Steiger K; Ntziachristos V; Schwaiger M; van Leeuwen FWB; Wester HJ
    J Nucl Med; 2019 Jan; 60(1):71-78. PubMed ID: 30237214
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
    J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety, Biodistribution, and Radiation Dosimetry of
    Tolvanen T; Kalliokoski K; Malaspina S; Kuisma A; Lahdenpohja S; Postema EJ; Miller MP; Scheinin M
    J Nucl Med; 2021 May; 62(5):679-684. PubMed ID: 33067338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histologically Confirmed Diagnostic Efficacy of
    Kroenke M; Wurzer A; Schwamborn K; Ulbrich L; Jooß L; Maurer T; Horn T; Rauscher I; Haller B; Herz M; Wester HJ; Weber WA; Eiber M
    J Nucl Med; 2020 May; 61(5):710-715. PubMed ID: 31836681
    [No Abstract]   [Full Text] [Related]  

  • 55. Biodistribution and Dosimetry of
    Pandit-Taskar N; Zanzonico P; Staton KD; Carrasquillo JA; Reidy-Lagunes D; Lyashchenko S; Burnazi E; Zhang H; Lewis JS; Blasberg R; Larson SM; Weber WA; Modak S
    J Nucl Med; 2018 Jan; 59(1):147-153. PubMed ID: 28705916
    [No Abstract]   [Full Text] [Related]  

  • 56. Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer.
    Harada N; Kimura H; Onoe S; Watanabe H; Matsuoka D; Arimitsu K; Ono M; Saji H
    J Nucl Med; 2016 Dec; 57(12):1978-1984. PubMed ID: 27417647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosimetry of
    Violet J; Jackson P; Ferdinandus J; Sandhu S; Akhurst T; Iravani A; Kong G; Kumar AR; Thang SP; Eu P; Scalzo M; Murphy D; Williams S; Hicks RJ; Hofman MS
    J Nucl Med; 2019 Apr; 60(4):517-523. PubMed ID: 30291192
    [No Abstract]   [Full Text] [Related]  

  • 58. [
    Rivera-Bravo B; Ramírez-Nava G; Mendoza-Figueroa MJ; Ocampo-García B; Ferro-Flores G; Ávila-Rodríguez MA; Santos-Cuevas C
    Nucl Med Biol; 2021; 96-97():54-60. PubMed ID: 33831746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.
    Prasad V; Steffen IG; Diederichs G; Makowski MR; Wust P; Brenner W
    Mol Imaging Biol; 2016 Jun; 18(3):428-36. PubMed ID: 27038316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetic modeling and parametric imaging of
    Yuan H; Zhang G; Sun T; Ren J; Zhang Q; Xiang Z; Liu E; Jiang L
    Med Phys; 2024 Jan; 51(1):156-166. PubMed ID: 38043120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.